The dominant expression of functional human lactoferrin in transgenic cloned goats using a hybrid lactoferrin expression construct

被引:20
作者
Yu, Huiqing [1 ,2 ]
Chen, Jianquan [1 ]
Sun, Wei [1 ]
Liu, Siguo [1 ]
Zhang, Aimin [1 ]
Xu, Xujun [1 ]
Wang, Xuebin [1 ]
He, Zhuzi [1 ]
Liu, Guohui [1 ]
Cheng, Guoxiang [1 ,2 ]
机构
[1] Shanghai Transgen Res Ctr, Shanghai 201210, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai 200025, Peoples R China
关键词
Dominant expression; Functional; Human lactoferrin; Cloned goat; Goat milk; RECOMBINANT HUMAN LACTOFERRIN; HIGH-LEVEL EXPRESSION; LARGE-SCALE PRODUCTION; MAMMARY-GLAND; ORAL TALACTOFERRIN; MILK; GENE; METASTASIS; BIOREACTOR; EFFICIENCY;
D O I
10.1016/j.jbiotec.2012.06.035
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Human Lactoferrin (hLF) is an iron-binding protein with multiple physiological functions. As the availability of natural hLF is limited, alternative means of producing this biopharmaceutical protein have been extensively studied. Here we report on the dominant expression of recombinant human lactoferrin (rhLF) in transgenic cloned goats using a novel optimised construct made by fusing a 3.3 kb hLF minigene to the regulatory elements of the beta-casein gene. The transgenic goat produced more than 30 mg/ml rhLF in its milk, and rhLF expression was stable during the entire lactation cycle. The rhLF purification efficiency from whole goat milk is approximately 70%, and its purity is above 98%. Compared with natural hLF, the rhLF from transgenic goats has similar biological characteristics including molecular mass, N-terminal sequence, isoelectric point, immunoreactivity and digestive stability. More importantly, the purified rhLF showed specific anti-tumour activity in the mouse model of melanoma experimental metastasis. Therefore, our study shows that the large-scale production of functional rhLF in transgenic goat milk could be an economical and promising source of human therapeutic use in the future. (C) 2012 Published by Elsevier B.V.
引用
收藏
页码:198 / 205
页数:8
相关论文
共 38 条
  • [1] Lactoferrin as a Natural Immune Modulator
    Actor, Jeffrey K.
    Hwang, Shen-An
    Kruzel, Marian L.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (17) : 1956 - 1973
  • [2] BEZAULT J, 1994, CANCER RES, V54, P2310
  • [3] INTRONS INCREASE TRANSCRIPTIONAL EFFICIENCY IN TRANSGENIC MICE
    BRINSTER, RL
    ALLEN, JM
    BEHRINGER, RR
    GELINAS, RE
    PALMITER, RD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (03) : 836 - 840
  • [4] Cerdán MG, 1998, MOL REPROD DEV, V49, P236, DOI 10.1002/(SICI)1098-2795(199803)49:3<236::AID-MRD3>3.0.CO
  • [5] 2-P
  • [6] The mammary gland as a bioreactor: Expression, processing, and production of recombinant proteins
    Clark, AJ
    [J]. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1998, 3 (03) : 337 - 350
  • [7] Phase IB trial of oral talactoferrin in the treatment of patients with metastatic solid tumors
    Hayes, Teresa G.
    Falchook, Gerald S.
    Varadhachary, Atul
    [J]. INVESTIGATIONAL NEW DRUGS, 2010, 28 (02) : 156 - 162
  • [8] Phase I trial of oral talactoferrin alfa in refractory solid tumors
    Hayes, TG
    Falchook, GF
    Varadhachary, GR
    Smith, DP
    Davis, LD
    Dhingra, HM
    Hayes, BP
    Varadhachary, A
    [J]. INVESTIGATIONAL NEW DRUGS, 2006, 24 (03) : 233 - 240
  • [9] Production of pharmaceutical proteins by transgenic animals
    Houdebine, Louis-Marie
    [J]. COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2009, 32 (02) : 107 - 121
  • [10] Lactoferrin and its biological functions
    Kanyshkova, TG
    Buneva, VN
    Nevinsky, GA
    [J]. BIOCHEMISTRY-MOSCOW, 2001, 66 (01) : 1 - 7